A5088980727- COVID-19 Clinical Research Studies
- Long-Term Effects of COVID-19
- Heart Failure Treatment and Management
- Cardiac Imaging and Diagnostics
- Acute Myocardial Infarction Research
- Sepsis Diagnosis and Treatment
- SARS-CoV-2 and COVID-19 Research
- Bacterial Identification and Susceptibility Testing
- Venous Thromboembolism Diagnosis and Management
- Vehicle emissions and performance
- Respiratory viral infections research
- Takotsubo Cardiomyopathy and Associated Phenomena
- Retinal and Optic Conditions
- Intensive Care Unit Cognitive Disorders
- Cardiac Health and Mental Health
- Viral Infections and Immunology Research
- COVID-19 and healthcare impacts
- Streptococcal Infections and Treatments
- Orthopedic Surgery and Rehabilitation
- Autoimmune and Inflammatory Disorders Research
- Dermatological and COVID-19 studies
- Respiratory Support and Mechanisms
- Air Quality and Health Impacts
- Vascular Procedures and Complications
- Coronary Interventions and Diagnostics
University of New Mexico
2022-2024
Coronavirus-19 (COVID-19), preliminarily a respiratory virus, can affect multiple organs, including the heart. Myocarditis is well-known complication among COVID-19 infections, with limited large-scale studies evaluating outcomes associated COVID-19-related Myocarditis. We used National Inpatient Sample (NIS) database to compare patients and without A total of 1,659,040 were included in study: (n = 6,455, 0.4%) 1,652,585, 99.6%). The primary outcome was in-hospital mortality. Secondary...
Abstract Respiratory failure in severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection appears related to cytokine release that often results mechanical ventilation (MV). We investigated the role of tocilizumab (TCZ) on interleukin‐6 (IL‐6) trends and MV patients with SARS‐CoV‐2. In this longitudinal observational study, 112 were evaluated from 1 February 31 May 2020. TCZ was administered followed by methylprednisolone >3L oxygen requirement pneumonia severity index score...
Background Coronavirus-19, primarily a respiratory virus, affects multiple organs and can lead to exacerbation of autoimmune or systemic conditions. Patients with diseases, rheumatoid arthritis particularly, are susceptible infection complications from COVID-19. RA has become well-associated COVID-19 infections, but large-scale studies evaluating outcomes among this vulnerable group limited. Methods For the retrospective analysis, we used National Inpatient Sample database compare patients...
Coronavirus-19, primarily a respiratory virus, also affects the nervous system. Acute ischemic stroke (AIS) is well-known complication among COVID-19 infections, but large-scale studies evaluating AIS outcomes related to infection remain limited. We used National Inpatient Sample database compare acute patients with and without COVID-19. A total of 329,240 were included in study: (n = 6665, 2.0%) 322,575, 98.0%). The primary outcome was in-hospital mortality. Secondary mechanical...
Abstract Recent literature suggests that approximately 5%–18% of patients diagnosed with severe acute respiratory syndrome coronavirus 2 may progress rapidly to a form the illness and subsequent death. We examined relationship between sociodemographic, clinical, laboratory findings mortality among patients. In this study, 112 were evaluated from February May 2020 80 met inclusion criteria. Tocilizumab was administered, followed by methylprednisolone pneumonia severity index score ≤130...
COVID-19 infections can lead to worse outcomes in an immunocompromised population with multiple comorbidities, e.g., heart transplant patients. We used the National Inpatient Sample database compare patients vs. influenza. A total of 2460 were included this study: (n = 1155, 47.0%) and influenza 1305, 53.0%) primary outcome in-hospital mortality. In-hospital mortality 120) was significantly higher for infected compared those (9.5% 0.8%, adjusted OR: 51.6 [95% CI 4.3–615.9], p 0.002) along...
Rapid administration of appropriately indicated antibiotics is crucial in septic patients. Sepsis data supports that there a higher risk mortality for each hour delay from triage to antibiotic therapy, as well inappropriate selection. There are variety rapid microbial detection systems, such VERIGENE®, used acute care facilities rapidly detect bacteremia and identify resistance markers. Our study investigates the usefulness VERIGENE® assays accurately detecting Gram-positive Gram-negative...
MAA3-O-05 Introduction: Trucking industry employees have regular mobile source exposures, including diesel and gasoline exhausts. Exposure varies with job title. Although all jobs, loading dock workers mechanics, occupational exposures to exhaust, only long-haul pick-up delivery (P&D) drivers constant exposures. Methods: We identified 54,319 employed in 1985 4 national trucking companies. Detailed monthly work histories were obtained from the companies mortality cause-of-death National Death...
Abstract Background The severity of respiratory failure in SARS-CoV-2 infection appears to be related cytokine release syndrome (CRS), resulting mechanical ventilation (MV). In this observational study, we investigated tocilizumab’s role the treatment and use interleukin-6 (IL-6) levels management these patients. Methods Patients with positive PCR were prospectively observed from February 1, 2020 May 31, 2020. Data on demographics, medical history, clinical outcomes collected. Tocilizumab...